NOVAVAX INC - Common Stock (NVAX)

CUSIP: 670002401

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock
Shares outstanding
163,049,608
Total 13F shares
52,556,924
Share change
+14,699,329
Total reported value
$540,013,841
Put/Call ratio
106%
Price per share
$10.28
Number of holders
236
Value change
+$137,141,602
Number of buys
123
Number of sells
91

Quarterly Holders Quick Answers

What is CUSIP 670002401?
CUSIP 670002401 identifies NVAX - NOVAVAX INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVAVAX INC - Common Stock (NVAX) as of Q4 2022

As of 31 Dec 2022, NOVAVAX INC - Common Stock (NVAX) was held by 236 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,556,924 shares. The largest 10 holders included VANGUARD GROUP INC, STATE STREET CORP, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VR Adviser, LLC, MORGAN STANLEY, CITIGROUP INC, MILLENNIUM MANAGEMENT LLC, Herr Investment Group LLC, and GOLDMAN SACHS GROUP INC. This page lists 236 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.